Current Directions in Biomedical Engineering (Sep 2023)

Discrepancy Between LGE-MRI and Electro-Anatomical Mapping for Regional Detection of Pathological Atrial Substrate

  • Goetz Christian,
  • Martínez Díaz Patricia,
  • Sánchez Jorge,
  • Jadidi Amir,
  • Eichenlaub Martin,
  • Dössel Olaf,
  • Loewe Axel

DOI
https://doi.org/10.1515/cdbme-2023-1121
Journal volume & issue
Vol. 9, no. 1
pp. 483 – 486

Abstract

Read online

Atrial fibrillation (AF) is the most common sustained arrhythmia posing a significant burden to patients and leading to an increased risk of stroke and heart failure. Additional ablation of areas of arrhythmogenic substrate in the atrial body detected by either late gadolinium enhancement magnetic resonance imaging (LGE-MRI) or electroanatomical mapping (EAM) may increase the success rate of restoring and maintaining sinus rhythm compared to the standard treatment procedure of pulmonary vein isolation (PVI). To evaluate if LGE-MRI and EAM identify equivalent substrate as potential ablation targets, we divided the left atrium (LA) into six clinically important regions in ten patients. Then, we computed the correlation between both modalities by analyzing the regional extents of identified pathological tissue. In this regional analysis, we observed no correlation between late gadolinium enhancement (LGE) and low voltage areas (LVA), neither in any region nor with regard to the entire atrial surface (-0.3<r<0.3). Instead, the regional extents identified as pathological tissue varied significantly between both modalities. An increased extent of LVA compared to LGE was observed in the septal wall of the LA (asept.,LVA= 19.63% and asept.,LGE= 3.94%, with = median of the extent of pathological tissue in the corresponding region). In contrast, in the inferior and lateral wall, the extent of LGE was higher than the extent of LVA for most geometries (ainf.,LGE= 27.22% and alat.,LGE= 32.70% compared to ainf.,LVA= 9.21% and alat.,LVA= 6.69%). Since both modalities provided discrepant results regarding the detection of arrhythmogenic substrate using clinically established thresholds, further investigations regarding their constraints need to be performed in order to use these modalities for patient stratification and treatment planning.

Keywords